Utility of Contrast-Enhanced FDG-PET/CT in the Clinical Management of Pancreatic Cancer | Zendy

Akinori Asagi | Zendy; Koji Ohta | Zendy; Junichirou Nasu | Zendy; Minoru Tanada | Zendy; Seijin Nadano | Zendy; Rieko Nishimura | Zendy; Norihiro Teramoto | Zendy; Kazuhide Yamamoto | Zendy; Takeshi Inoue | Zendy; Haruo Iguchi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Utility of Contrast-Enhanced FDG-PET/CT in the Clinical Management of Pancreatic Cancer

Author(s) -

Akinori Asagi,

Koji Ohta,

Junichirou Nasu,

Minoru Tanada,

Seijin Nadano,

Rieko Nishimura,

Norihiro Teramoto,

Kazuhide Yamamoto,

Takeshi Inoue,

Haruo Iguchi

Publication year - 2012

Publication title -

pancreas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.061

H-Index - 104

eISSN - 1536-4828

pISSN - 0885-3177

DOI - 10.1097/mpa.0b013e3182550d77

Subject(s) - medicine , pancreatic cancer , positron emission tomography , standardized uptake value , nuclear medicine , radiology , context (archaeology) , differential diagnosis , pet ct , cancer , metastasis , lymph node , pancreas , pathology , paleontology , biology

Fluorodeoxyglucose (FDG)-positron emission tomography/contrast-enhanced computed tomography (PET/CE-CT) involving whole-body scanning first by non-CE-CT and FDG-PET followed by CE-CT has been used for detailed examination of pancreatic lesions. We evaluated PET/CE-CT images with regard to differential diagnosis, staging, treatment response, and postoperative recurrence in pancreatic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research